Buys
Open market- Shares
- Avg price
- Total value
Suma M. Krishnan - President, R&D, Director, 10%+ Owner at Krystal Biotech, Inc.
Issuer-level insider activity
- Role
- President, R&D, Director, 10%+ Owner
- Issuer ticker
- KRYS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Suma M. Krishnan in Krystal Biotech, Inc.
Sells
Open market- Shares
- -100,000
- Avg price
- $252.90
- Total value
- -$25,290,428
Net
Past year- Shares
- -100,000
- Share %
- -100%
- Total value
- -$25,290,428
Reported holdings for Suma M. Krishnan in Krystal Biotech, Inc.
Form 4 holding
President, R&D, Director, 10%+ Owner
Krystal Biotech, Inc.
- Security class
- Common Stock
- Shares / value
- 1,378,155
- Estimated value
- $429,502,005
- Report date
- 04 Jun 2026
- Price
- $311.65
- Ownership
- Direct
Form 4 holding
President, R&D, Director, 10%+ Owner
Krystal Biotech, Inc.
- Security class
- Common Stock
- Shares / value
- 90,000
- Estimated value
- $24,538,500
- Report date
- 04 Mar 2026
- Price
- $272.65
- Ownership
- By SMK Trust
Form 4 holding
President, R&D, Director, 10%+ Owner
Krystal Biotech, Inc.
- Security class
- Common Stock
- Shares / value
- 90,000
- Estimated value
- $23,248,800
- Report date
- 04 Jun 2026
- Price
- $258.32
- Ownership
- By Krishnan Spousal Trust
Form 4 holding
President, R&D, Director, 10%+ Owner
Krystal Biotech, Inc.
- Security class
- Common Stock
- Shares / value
- 50,000
- Estimated value
- $12,916,000
- Report date
- 04 Jun 2026
- Price
- $258.32
- Ownership
- By Krishnan Family Trust
Form 4 holding
President, R&D, Director, 10%+ Owner
Krystal Biotech, Inc.
- Security class
- Performance Stock Units
- Shares / value
- 43,536
- Estimated value
- $3,968,775
- Report date
- 27 Feb 2026
- Price
- $176.39
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President, R&D, Director, 10%+ Owner
Krystal Biotech, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 7,256
- Estimated value
- $2,822,240
- Report date
- 27 Feb 2026
- Price
- $176.39
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President, R&D, Director, 10%+ Owner
Krystal Biotech, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 18,100
- Estimated value
- Report date
- 27 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Suma M. Krishnan in Krystal Biotech, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.